Logo image of MAR.LS

MARTIFER SGPS SA (MAR.LS) Stock Fundamental Analysis

ELI:MAR - Euronext Lisbon - PTMFR0AM0003 - Common Stock - Currency: EUR

1.895  +0.01 (+0.53%)

Fundamental Rating

5

Taking everything into account, MAR scores 5 out of 10 in our fundamental rating. MAR was compared to 40 industry peers in the Construction & Engineering industry. MAR has an average financial health and profitability rating. MAR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year MAR was profitable.
MAR had a positive operating cash flow in the past year.
MAR had positive earnings in each of the past 5 years.
MAR had a positive operating cash flow in each of the past 5 years.
MAR.LS Yearly Net Income VS EBIT VS OCF VS FCFMAR.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M

1.2 Ratios

MAR's Return On Assets of 6.60% is fine compared to the rest of the industry. MAR outperforms 80.00% of its industry peers.
MAR has a Return On Equity of 32.66%. This is in the better half of the industry: MAR outperforms 80.00% of its industry peers.
With a decent Return On Invested Capital value of 9.00%, MAR is doing good in the industry, outperforming 62.50% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MAR is significantly below the industry average of 20.30%.
Industry RankSector Rank
ROA 6.6%
ROE 32.66%
ROIC 9%
ROA(3y)5.64%
ROA(5y)5.49%
ROE(3y)44.66%
ROE(5y)106.18%
ROIC(3y)11.81%
ROIC(5y)11.56%
MAR.LS Yearly ROA, ROE, ROICMAR.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400

1.3 Margins

The Profit Margin of MAR (9.18%) is better than 82.50% of its industry peers.
MAR's Profit Margin has improved in the last couple of years.
The Operating Margin of MAR (9.11%) is better than 72.50% of its industry peers.
MAR's Operating Margin has improved in the last couple of years.
MAR has a worse Gross Margin (30.59%) than 62.50% of its industry peers.
In the last couple of years the Gross Margin of MAR has remained more or less at the same level.
Industry RankSector Rank
OM 9.11%
PM (TTM) 9.18%
GM 30.59%
OM growth 3Y17.6%
OM growth 5Y12.44%
PM growth 3Y52.48%
PM growth 5Y71.65%
GM growth 3Y0.1%
GM growth 5Y0.47%
MAR.LS Yearly Profit, Operating, Gross MarginsMAR.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

MAR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, MAR has about the same amount of shares outstanding.
The number of shares outstanding for MAR remains at a similar level compared to 5 years ago.
MAR has a better debt/assets ratio than last year.
MAR.LS Yearly Shares OutstandingMAR.LS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
MAR.LS Yearly Total Debt VS Total AssetsMAR.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 1.71, we must say that MAR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.71, MAR perfoms like the industry average, outperforming 45.00% of the companies in the same industry.
The Debt to FCF ratio of MAR is 1.92, which is an excellent value as it means it would take MAR, only 1.92 years of fcf income to pay off all of its debts.
MAR's Debt to FCF ratio of 1.92 is fine compared to the rest of the industry. MAR outperforms 77.50% of its industry peers.
MAR has a Debt/Equity ratio of 1.62. This is a high value indicating a heavy dependency on external financing.
MAR has a Debt to Equity ratio of 1.62. This is amonst the worse of the industry: MAR underperforms 80.00% of its industry peers.
Even though the debt/equity ratio score it not favorable for MAR, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.62
Debt/FCF 1.92
Altman-Z 1.71
ROIC/WACC1.46
WACC6.18%
MAR.LS Yearly LT Debt VS Equity VS FCFMAR.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

MAR has a Current Ratio of 1.53. This is a normal value and indicates that MAR is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.53, MAR is doing good in the industry, outperforming 72.50% of the companies in the same industry.
MAR has a Quick Ratio of 1.44. This is a normal value and indicates that MAR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of MAR (1.44) is better than 77.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.44
MAR.LS Yearly Current Assets VS Current LiabilitesMAR.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.92% over the past year.
The Earnings Per Share has been growing by 82.06% on average over the past years. This is a very strong growth
The Revenue has grown by 13.10% in the past year. This is quite good.
The Revenue has been growing slightly by 0.22% on average over the past years.
EPS 1Y (TTM)76.92%
EPS 3Y49.38%
EPS 5Y82.06%
EPS Q2Q%33.33%
Revenue 1Y (TTM)13.1%
Revenue growth 3Y-4.09%
Revenue growth 5Y0.22%
Sales Q2Q%20.08%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MAR.LS Yearly Revenue VS EstimatesMAR.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
MAR.LS Yearly EPS VS EstimatesMAR.LS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.24, which indicates a very decent valuation of MAR.
Based on the Price/Earnings ratio, MAR is valued cheaper than 87.50% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.07. MAR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.24
Fwd PE N/A
MAR.LS Price Earnings VS Forward Price EarningsMAR.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

MAR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MAR is cheaper than 95.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.12
EV/EBITDA N/A
MAR.LS Per share dataMAR.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

The decent profitability rating of MAR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MAR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARTIFER SGPS SA

ELI:MAR (3/25/2025, 7:00:00 PM)

1.895

+0.01 (+0.53%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.4%
Inst Owner ChangeN/A
Ins Owners5.9%
Ins Owner ChangeN/A
Market Cap189.50M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)-17.69%
DP0.74%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.24
Fwd PE N/A
P/S 0.79
P/FCF 3.12
P/OCF 2.94
P/B 2.8
P/tB 3.36
EV/EBITDA N/A
EPS(TTM)0.23
EY12.14%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.61
FCFY32.04%
OCF(TTM)0.65
OCFY34.05%
SpS2.41
BVpS0.68
TBVpS0.56
PEG (NY)N/A
PEG (5Y)0.1
Profitability
Industry RankSector Rank
ROA 6.6%
ROE 32.66%
ROCE 11.39%
ROIC 9%
ROICexc 22.88%
ROICexgc 26.91%
OM 9.11%
PM (TTM) 9.18%
GM 30.59%
FCFM 25.19%
ROA(3y)5.64%
ROA(5y)5.49%
ROE(3y)44.66%
ROE(5y)106.18%
ROIC(3y)11.81%
ROIC(5y)11.56%
ROICexc(3y)18.91%
ROICexc(5y)17.33%
ROICexgc(3y)21.32%
ROICexgc(5y)19.6%
ROCE(3y)14.94%
ROCE(5y)14.64%
ROICexcg growth 3Y22.95%
ROICexcg growth 5Y26.93%
ROICexc growth 3Y21.77%
ROICexc growth 5Y26.25%
OM growth 3Y17.6%
OM growth 5Y12.44%
PM growth 3Y52.48%
PM growth 5Y71.65%
GM growth 3Y0.1%
GM growth 5Y0.47%
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.62
Debt/FCF 1.92
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.58%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 274.31%
Current Ratio 1.53
Quick Ratio 1.44
Altman-Z 1.71
F-Score5
WACC6.18%
ROIC/WACC1.46
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.69%
Cap/Sales(5y)0.58%
Profit Quality(3y)119.27%
Profit Quality(5y)109.71%
High Growth Momentum
Growth
EPS 1Y (TTM)76.92%
EPS 3Y49.38%
EPS 5Y82.06%
EPS Q2Q%33.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.1%
Revenue growth 3Y-4.09%
Revenue growth 5Y0.22%
Sales Q2Q%20.08%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.83%
EBIT growth 3Y12.79%
EBIT growth 5Y12.69%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y317.78%
FCF growth 3Y71.92%
FCF growth 5Y31.93%
OCF growth 1Y305.15%
OCF growth 3Y64.12%
OCF growth 5Y29.12%